he number of biotechnology products on the market and, particularly, in development has increased enormously during the past decade. Biological products generally are more complex than their small-molecule counterparts. Some product variants — such as deamidated, clipped, aggregated, or misfolded species — could be present in the process stream and even in the final products. Regulatory agencie...
